The BIOCEV Scientific Research Centre comes into operation. Up to 600 scientists and students to work there

A unique vaccine to treat infectious diseases, the first ever research into development of the tooth that can help to fight against cancer, or the revolutionary discovery of “power plant cells” – an organism without mitochondria… These are some of the results of scientific teams at the BIOCEV centre. Today, at presence of national political representatives and prominent guests representing the Czech as well as international world of science, the centre officially came into full operation.

The biotechnological and biomedical centre of the Czech Academy of Sciences and Charles University in Vestec (BIOCEV) was created with considerable financial support of the European Union. The grant application comprised 1,600 pages and the implementation cost 2.3 billion Czech crowns. By 2020, as many as 400 scientists and 200 undergraduate and postgraduate students should be working there. At the time, there are as many as 56 research teams, active in five synergic programmes, which deal with detailed study of organisms at the molecular level. Their results induce applied research and development of new therapeutic techniques for serious health conditions. The end-products of scientific work at the BIOCEV centre include drugs targeted to the exact site of damaged metabolism, or protein and tissue engineering.